CTRI/2008/091/000021已完成1 期
Efficacy and safety evaluation of a Siddha medicine HIVS-2004 for HIV/AIDS
daykumar Ranga, JNCASR, Bangalore0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Seropositive for HIV-1 by three different ELISAs or one ELISA and Western blot confirmation. CD4 clount 200-250 cells per ml. Drug-naive. Both genders. Age above 18 years.
排除标准
- •Presence of opportunistic infections and complications such as Dementia. Signs of acute systemic Illness (CVS, CNS, RS, GU, Liver etc.). Prior-antiretroviral treatment.
研究者
相似试验
尚未招募
3 期
Evaluating therapeutic efficacy of VASANTHAKUSUMAKARAM MATHIRAI for PITHA NEER CHURUKU(Urinary Tract Infection)CTRI/2023/03/050696ational Institute Of Siddha
已完成
3 期
Parangipattai Rasayanam in the management of kaalaanjagappadai(psoriasis)CTRI/2018/02/011904ATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM CHENNAI40
尚未招募
2 期
Siddha drug veppampoo Mathirai for Blood pressureCTRI/2022/02/040005Self
进行中（未招募）
3 期
study of siddha drug-Aavaaraividai churnam for Diabetes MellitusCTRI/2015/02/005512Dr K S Uma100
尚未招募
3 期
Thiratchai Chooranam for the treatment of Vatha Paandu(Megaloblastic Anemia)CTRI/2020/01/022603ational Institute of Siddha